The recombinant quadrivalent human papillomavirus vaccine [Gardasil] has been approved in New Zealand

Source: Inpharma, Volume 1, Number 1548, 2006-07-29 , pp. 23-23(1)

Publisher: Adis International

Keywords: Adolescents; Cervical-cancer, prevention; Children; Development-status; Human-papillomavirus-infections, prevention; Human-papillomavirus-vaccine-recombinant-quadrival; Product-approvals; Research-and-development; Vaccines, immunogenicity

Document Type: Short communication

Publication date: 2006-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers